Enrique Carrazana
Director/Board Member chez Hawaii Biotech, Inc.
Profil
Enrique J.
Carrazana is currently the Director at Hawaii Biotech, Inc., the Director at Cnd Life Sciences, Inc., and the Senior Vice President-Strategic Initiatives at Neurelis, Inc. He previously served as the Independent Director at Marinus Pharmaceuticals, Inc. from 2013 to 2021.
He also held positions as the Director-Epilepsy Center of Excellence at Miami VA Health Care System, the Chief Medical Officer at Acorda Therapeutics, Inc. from 2011 to 2016, and the Vice President & Head-Global Development at Novartis AG from 2001 to 2010.
Additionally, he was an Associate Professor at The University of Miami Leonard M.
Miller School of Medicine from 2010 to 2011.
Dr. Carrazana obtained his doctorate degree from Harvard Medical School in 1987.
Postes actifs de Enrique Carrazana
| Sociétés | Poste | Début |
|---|---|---|
Hawaii Biotech, Inc.
 Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Director/Board Member | - |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 15/05/2023 |
Cnd Life Sciences, Inc.
 Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Director/Board Member | 07/09/2021 |
Anciens postes connus de Enrique Carrazana
| Sociétés | Poste | Fin |
|---|---|---|
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 30/06/2021 |
| ACORDA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 04/01/2016 |
| The University of Miami Leonard M. Miller School of Medicine | Corporate Officer/Principal | 01/09/2011 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2010 |
| Miami VA Health Care System / Research | Corporate Officer/Principal | - |
Formation de Enrique Carrazana
| Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 4 |
|---|---|
Hawaii Biotech, Inc.
Hawaii Biotech, Inc. Pharmaceuticals: OtherHealth Technology Hawaii Biotech, Inc. operates as a biotechnology company that focuses on the research and development of vaccines for established and emerging infectious diseases. It has developed proprietary expertise in the production of recombinant proteins applicable to the development of safe and effective vaccines. The firm's products include anti-toxin drugs for the lethal factor from B. anthracis and the botulinum toxin from C. botulinum. The company was founded in 1982 and is headquartered in Honolulu, HI. | Health Technology |
| Miami VA Health Care System / Research | |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
Cnd Life Sciences, Inc.
Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Health Services |
